• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Roux-en-Y 胃旁路手术对小鼠非酒精性脂肪性肝病缓解的体重独立作用。

Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice.

机构信息

Integrative Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA.

出版信息

Obesity (Silver Spring). 2023 Dec;31(12):2960-2971. doi: 10.1002/oby.23876. Epub 2023 Sep 20.

DOI:10.1002/oby.23876
PMID:37731222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10895705/
Abstract

OBJECTIVE

Obesity is a driver of non-alcoholic fatty liver disease (NAFLD), and interventions that decrease body weight, such as bariatric surgery and/or calorie restriction (CR), may serve as effective therapies. This study compared the effects of Roux-en-Y gastric bypass surgery (RYGB) and CR on hepatic function in mice with obesity and NAFLD.

METHODS

C57BL/6J mice were fed a high-fat diet to promote obesity. At 16 weeks of age, mice were randomized to sham surgery (sham), RYGB, or CR weight matched to RYGB (WM). Body weight/composition, food intake, and energy expenditure (EE) were measured throughout treatment. Liver histopathology was evaluated from H&E-stained sections. Hepatic enzymes and glycogen content were determined by ELISA. Transcriptional signatures were revealed via RNA sequencing.

RESULTS

RYGB reduced hepatic lipid content and adiposity while increasing EE and lean body mass relative to WM. Hepatic glycogen and bile acid content were increased after RYGB relative to sham and WM. RYGB activated enterohepatic signaling and genes regulating hepatic lipid homeostasis.

CONCLUSIONS

RYGB improved whole-body composition and hepatic lipid homeostasis to a greater extent than CR in mice. RYGB was associated with discrete remodeling of the hepatic transcriptome, suggesting that surgery may be mechanistically additive to CR.

摘要

目的

肥胖是导致非酒精性脂肪性肝病(NAFLD)的一个因素,而减轻体重的干预措施,如减重手术和/或热量限制(CR),可能是有效的治疗方法。本研究比较了肥胖合并 NAFLD 小鼠中 Roux-en-Y 胃旁路手术(RYGB)和 CR 对肝功能的影响。

方法

C57BL/6J 小鼠喂食高脂肪饮食以促进肥胖。在 16 周龄时,将小鼠随机分为假手术(sham)、RYGB 和与 RYGB 体重匹配的 CR(WM)组。在整个治疗过程中测量体重/成分、食物摄入量和能量消耗(EE)。通过 H&E 染色切片评估肝组织病理学。通过 ELISA 测定肝酶和糖原含量。通过 RNA 测序揭示转录特征。

结果

RYGB 与 WM 相比,降低了肝脂质含量和脂肪堆积,同时增加了 EE 和瘦体重。与 sham 和 WM 相比,RYGB 后肝糖原和胆汁酸含量增加。RYGB 激活了肠肝信号转导和调节肝脂质稳态的基因。

结论

RYGB 改善了全身成分和肝脂质稳态,比 CR 更显著。RYGB 与肝转录组的离散重塑有关,表明手术可能与 CR 具有机制上的相加作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/d4ab340011d7/nihms-1966748-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/1a41164dd180/nihms-1966748-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/471544924216/nihms-1966748-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/16551266155a/nihms-1966748-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/d4ab340011d7/nihms-1966748-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/1a41164dd180/nihms-1966748-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/471544924216/nihms-1966748-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/16551266155a/nihms-1966748-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb5c/10895705/d4ab340011d7/nihms-1966748-f0004.jpg

相似文献

1
Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice.Roux-en-Y 胃旁路手术对小鼠非酒精性脂肪性肝病缓解的体重独立作用。
Obesity (Silver Spring). 2023 Dec;31(12):2960-2971. doi: 10.1002/oby.23876. Epub 2023 Sep 20.
2
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.Roux-en-Y胃旁路手术可诱导肝脏转录组特征和血浆代谢物变化,提示胆固醇稳态得到改善。
J Hepatol. 2023 Oct;79(4):898-909. doi: 10.1016/j.jhep.2023.05.012. Epub 2023 May 23.
3
Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.法尼酯X受体有助于饮食诱导肥胖小鼠行Roux-en-Y胃旁路手术后血糖控制的改善,且这种改善与体重无关。
Mol Metab. 2020 Jul;37:100980. doi: 10.1016/j.molmet.2020.100980. Epub 2020 Mar 19.
4
Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice.TGR5 缺陷型和野生型小鼠的 Roux-en-Y 胃旁路手术诱导的体重减轻和代谢改善相似。
Obes Surg. 2018 Oct;28(10):3227-3236. doi: 10.1007/s11695-018-3297-6.
5
Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.Roux-en-Y 胃旁路手术通过增加血清胆汁酸水平和肝法尼醇 X 受体表达改善 2 型糖尿病大鼠模型的代谢状况。
Obes Surg. 2019 Sep;29(9):2912-2922. doi: 10.1007/s11695-019-03918-0.
6
Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic lipogenesis in offspring.肥胖大鼠 Roux-en-Y 胃旁路手术后妊娠和哺乳会加重非酒精性脂肪性肝病,并导致后代肝脏脂肪生成的差异编程。
J Dev Orig Health Dis. 2022 Apr;13(2):263-273. doi: 10.1017/S2040174421000271. Epub 2021 May 17.
7
The Effect of Diet Composition on the Post-operative Outcomes of Roux-en-Y Gastric Bypass in Mice.饮食构成对小鼠 Roux-en-Y 胃旁路手术后结果的影响。
Obes Surg. 2024 Mar;34(3):911-927. doi: 10.1007/s11695-023-07052-w. Epub 2024 Jan 8.
8
Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery.Roux-en-Y胃旁路手术小鼠模型中的身体成分、食物摄入量和能量消耗
Obes Surg. 2016 Sep;26(9):2173-2182. doi: 10.1007/s11695-016-2062-y.
9
Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.胃旁路手术可预防高脂饮食诱导的非酒精性脂肪性肝病和肝脏内质网应激。
Acta Physiol (Oxf). 2016 Jun;217(2):141-51. doi: 10.1111/apha.12640. Epub 2015 Dec 29.
10
Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.Roux-en-Y胃旁路手术在2型糖尿病大鼠模型中抑制肝糖异生并增加肠糖异生。
Obes Surg. 2016 Nov;26(11):2683-2690. doi: 10.1007/s11695-016-2157-5.

引用本文的文献

1
Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions.调节胆汁酸信号通路治疗非酒精性脂肪性肝病:分子机制与新型治疗干预措施
Front Microbiol. 2024 Jun 3;15:1341938. doi: 10.3389/fmicb.2024.1341938. eCollection 2024.
2
Restricting bioenergetic efficiency enhances longevity and mitochondrial redox capacity in Drosophila melanogaster.限制生物能量效率可延长黑腹果蝇的寿命并增强其线粒体氧化还原能力。
Aging Cell. 2024 May;23(5):e14107. doi: 10.1111/acel.14107. Epub 2024 Feb 11.

本文引用的文献

1
Obesity Management in the Primary Prevention of Hepatocellular Carcinoma.肝细胞癌一级预防中的肥胖管理
Cancers (Basel). 2022 Aug 22;14(16):4051. doi: 10.3390/cancers14164051.
2
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.地中海饮食和热量限制对非酒精性脂肪性肝病(NAFLD)的有效性和可接受性:系统评价和荟萃分析。
Clin Nutr. 2022 Sep;41(9):1913-1931. doi: 10.1016/j.clnu.2022.06.037. Epub 2022 Jul 2.
3
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
4
Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control.线粒体解偶联通过增强骨骼肌自噬和质量控制来减轻肥胖型骨骼肌减少症。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1821-1836. doi: 10.1002/jcsm.12982. Epub 2022 Mar 19.
5
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.减肥手术与经活检证实的非酒精性脂肪性肝炎患者的肝脏和心血管主要不良结局的关联
JAMA. 2021 Nov 23;326(20):2031-2042. doi: 10.1001/jama.2021.19569.
6
Breast cancer growth and proliferation is suppressed by the mitochondrial targeted furazano[3,4-b]pyrazine BAM15.线粒体靶向的呋咱并[3,4-b]吡嗪BAM15可抑制乳腺癌的生长和增殖。
Cancer Metab. 2021 Oct 9;9(1):36. doi: 10.1186/s40170-021-00274-5.
7
A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men.体重增加 1.5 公斤或更多以及缺乏运动与男性非酒精性脂肪肝疾病的复发有关。
Sci Rep. 2021 Oct 7;11(1):19992. doi: 10.1038/s41598-021-99036-y.
8
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption.FXR 激活通过依赖于胆汁酸的脂质吸收减少来预防 NAFLD。
Cell Metab. 2021 Aug 3;33(8):1671-1684.e4. doi: 10.1016/j.cmet.2021.06.012. Epub 2021 Jul 15.
9
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:通过饮食和运动来实现减肥以治疗非酒精性脂肪性肝病的生活方式干预:专家综述。
Gastroenterology. 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9.
10
Bile Acids and FXR: Novel Targets for Liver Diseases.胆汁酸与法尼醇X受体:肝脏疾病的新靶点
Front Med (Lausanne). 2020 Sep 11;7:544. doi: 10.3389/fmed.2020.00544. eCollection 2020.